FDA Inspection 1092804 — UF Reproductive Medicine at Springhill
The FDA completed an inspection of UF Reproductive Medicine at Springhill on June 6, 2019 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 6, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Gainesville, FL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12222 | 21 CFR 1271.47(a) | Design of procedures to ensure compliance |
| 12493 | 21 CFR 1271.90(c) | Eligibility not required--warning labels |